CLARA represents the interdisciplinary Center of Excellence, the first of its kind in Central and Eastern Europe, focusing on the next generation of artificial intelligence and machine learning applications and quantum-centric supercomputing tools to push the frontier of neurodegeneration research, particularly Alzheimer‘s disease, by processing large-scale multidimensional biological and clinical data using powerful supercomputers and quantum methods.
Show more Hide
There are over 50 million people worldwide living with dementia today, and this number is expected to reach 82 million by 2030. According to the World Alzheimer Report 2020, the global annual cost of dementia is estimated to be more than US$ 1 trillion and is forecasted to double by 2030.
We believe that Europe as a whole has the most up-to-date scientific and clinical knowledge to understand the complexities of neurodegeneration and to develop new technological and therapeutic innovations. Europe has long been a major driver of global innovation but has recently lagged behind in growth sectors and in areas of innovation such as genomics, quantum computing and artificial intelligence.
CLARA will use Europe’s full potential and contribute to change.
The grand challenge of vitality and longevity of neurons The conventional approach in dementia research to explain neurodegenerative diseases such as Alzheimer's is to focus on presumed mechanisms of neuronal dysfunction leading to failure in particular neural systems. CLARA wants to be more ahead of the curve and is therefore tasking a bold new question: What are the essential conditions to maintain optimal function, vitality, and longevity of neurons for over 100 years?
Show more HideIn CLARA, cutting-edge technologies meet groundbreaking research in neurodegenerative diseases (NDs). In CLARA, we explore the complex interactions between molecular, behavioural, and clinical aspects of NDs through the integration of Quantum Computing (QC), High-Performance Computing (HPC), and Hybrid Computing (HPCQC), powered by Artificial Intelligence (AI) and Machine Learning (ML). By harnessing deep domain expertise and processing large-scale biological and clinical data, CLARA aims to advance our understanding of these transformative technologies. Our work accelerates innovation in computing, tackling real-world challenges, and ultimately benefiting society.
Show more HideCLARA serves as a catalyst for cross-institutional and interdisciplinary collaboration, bringing together the best teams from diverse institutions under a shared scientific vision. By fostering strong connections between different disciplines and research organizations, CLARA ensures a flexible, transparent, and innovative approach to governance. Built on a solid legal and scientific foundation, CLARA establishes a groundbreaking organizational platform that unites top-tier R&D&I teams from across the Czech Republic and beyond, driving innovation and excellence.
Show more HideProject title | Center for Artificial Intelligence and Quantum Computing in System Brain Research |
Acronym | CLARA |
ID code | 101136607 – call:
HORIZON-WIDERA-2023-ACCESS-01 CZ.02.01.01/00/23_029/0008437 - OP JAK (in the approval process) |
Total Budget | 43 mil. EUR: Horizon Europe: 15 mil. EUR OP JAK: 28 mil. EUR (in the approval process) |
Consortium |
Czech Republic: INDRC – International Neurodegenerative Disorders Research Center (Coordinator) CIIRC CTU – Czech Institute of Informatics, Robotics and Cybernetics CTU in Prague VSB-TUO – Technical University of Ostrava | IT4Innovations ICRC – International Clinical Research Center, St. Anne’s University Hospital Brno PBI - Paris Brain Institute, France LRZ – Leibniz Supercomputing Centre, Bavarian Academy of Sciences and Humanities, Germany |
This project has received funding from the European Union's Horizon Europe Framework Programme under Grant Agreement No. 101136607.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Union nor the granting authority can be held responsible for them.